Chief Financial Officer · FATE THERAPEUTICS INC (FATE)

Edward Dulac

A named executive officer of FATE THERAPEUTICS in every fiscal year CompBrief holds from FY2020 to FY2023. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$2,824,498

Salary $475,000Stock awards $0

FY2022: $3,157,751

4th of 4 named executive officers at Fate Therapeutics by FY2023 total.

4 named officers on file for FATE THERAPEUTICS, FY2023

Edward Dulac’s pay file — $29

  • 4 fiscal years of pay, line by line
  • 5 equity grants, each cited to its filing
  • FATE’s disclosed peer group of 19 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how FATE THERAPEUTICS’s whole pay program stands against its peers

  • FATE THERAPEUTICS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on FATE→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 26, 2024 (DEF 14A).

Free

Get Edward Dulac’s full pay file as a PDF — free

More than this page: up to 10 years of Edward’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Edward Dulac compensation by year

FATE THERAPEUTICS Summary Compensation Table · all 4 fiscal years held
In US dollars, as FATE THERAPEUTICS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2021FY2022FY2023
Salary$142,500$420,000$455,000$475,000
Bonus$137,917—$0$0
Stock awards$1,420,800$5,296,051$1,327,751$0
Option awards$3,786,529$500,000$1,375,000$2,211,998
Non-equity incentive$75,833$168,000$0$133,000
Pension and deferred compensation$0$0$0$0
All other$120,000$0$0$4,500
Total$5,683,579$6,384,051$3,157,751$2,824,498

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: FATE THERAPEUTICS INC DEF 14A filed April 26, 2024, accession 0001193125-24-117981, and prior-year filings.

How this page was built: the FATE THERAPEUTICS INC filed document, accession 0001193125-24-117981. Every figure is read from that document and cited to the page and table it appears in. Filed April 26, 2024.

$5.7M
$6.4M
$3.2M
$2.8M
FY20
FY21
FY22
FY23
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2023 year-end
TypeUnvested unitsValue at year-endExercise price
PSU59,540$222,680—
RSU24,977$93,414—
RSU10,000$37,400—
RSU9,007$33,686—
Option26,667—$35.52
Option1,859—$109.01
Option27,643—$39.87
Option295,145—$6.77

Per the Outstanding Equity Awards at Fiscal Year-End table in FATE THERAPEUTICS INC's FY2023 proxy; value at the fiscal year-end close, as the company printed it.

FATE THERAPEUTICS’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
J. Scott WolchkoPresident, Chief Executive Officer and Director$3,522,750
Bahram ValamehrChief Research and Development Officer$2,986,615
Cindy TahlGeneral Counsel and Corporate Secretary$2,824,498
Edward Dulac · this pageChief Financial Officer$2,824,498

The full FATE THERAPEUTICS compensation record

free company brief

This page is one person within FATE THERAPEUTICS's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the FATE THERAPEUTICS proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are FATE THERAPEUTICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Edward Dulac's compensation dossier · One-time report. No refunds.